Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.

Pistelli M, Caramanti M, Biscotti T, Santinelli A, Pagliacci A, De Lisa M, Ballatore Z, Ridolfi F, Maccaroni E, Bracci R, Berardi R, Battelli N, Cascinu S.

Cancers (Basel). 2014 Jun 27;6(3):1351-62. doi: 10.3390/cancers6031351.

PMID:
24978437
[PubMed]
Free Article
2.

The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.

Tang D, Xu S, Zhang Q, Zhao W.

Med Oncol. 2012 Jun;29(2):526-33. doi: 10.1007/s12032-011-9948-2. Epub 2011 Apr 26.

PMID:
21519872
[PubMed - indexed for MEDLINE]
3.

Expression of androgen receptors in triple negative breast carcinomas.

Mrklić I, Pogorelić Z, Capkun V, Tomić S.

Acta Histochem. 2013 May;115(4):344-8. doi: 10.1016/j.acthis.2012.09.006. Epub 2012 Sep 29.

PMID:
23031358
[PubMed - indexed for MEDLINE]
4.

Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.

McNamara KM, Yoda T, Miki Y, Chanplakorn N, Wongwaisayawan S, Incharoen P, Kongdan Y, Wang L, Takagi K, Mayu T, Nakamura Y, Suzuki T, Nemoto N, Miyashita M, Tamaki K, Ishida T, Ohuchi N, Sasano H.

Cancer Sci. 2013 May;104(5):639-46. doi: 10.1111/cas.12121. Epub 2013 Mar 15.

PMID:
23373898
[PubMed - indexed for MEDLINE]
5.

Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer.

Choi JE, Kang SH, Lee SJ, Bae YK.

Ann Surg Oncol. 2014 Aug 22. [Epub ahead of print]

PMID:
25145503
[PubMed - as supplied by publisher]
6.

Clinicopathological features of triple-negative breast cancer in Taiwanese women.

Yao-Lung K, Dar-Ren C, Tsai-Wang C.

Int J Clin Oncol. 2011 Oct;16(5):500-5. doi: 10.1007/s10147-011-0211-9. Epub 2011 Apr 1.

PMID:
21455625
[PubMed - indexed for MEDLINE]
7.

Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype.

McGhan LJ, McCullough AE, Protheroe CA, Dueck AC, Lee JJ, Nunez-Nateras R, Castle EP, Gray RJ, Wasif N, Goetz MP, Hawse JR, Henry TJ, Barrett MT, Cunliffe HE, Pockaj BA.

Ann Surg Oncol. 2014 Feb;21(2):361-7. doi: 10.1245/s10434-013-3260-7. Epub 2013 Sep 18.

PMID:
24046116
[PubMed - in process]
8.

Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.

He J, Peng R, Yuan Z, Wang S, Peng J, Lin G, Jiang X, Qin T.

Med Oncol. 2012 Jun;29(2):406-10. doi: 10.1007/s12032-011-9832-0. Epub 2011 Jan 25.

PMID:
21264529
[PubMed - indexed for MEDLINE]
9.

Novel prognostic markers for patients with triple-negative breast cancer.

Zhou L, Li K, Luo Y, Tian L, Wang M, Li C, Huang Q.

Hum Pathol. 2013 Oct;44(10):2180-7. doi: 10.1016/j.humpath.2013.03.021. Epub 2013 Jul 8.

PMID:
23845466
[PubMed - indexed for MEDLINE]
10.

Significance of E-cadherin expression in triple-negative breast cancer.

Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, Ishikawa T, Wakasa K, Hirakawa K.

Br J Cancer. 2010 Jul 13;103(2):249-55. doi: 10.1038/sj.bjc.6605735. Epub 2010 Jun 15.

PMID:
20551954
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Expression of androgen receptors in primary breast cancer.

Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, Park BW, Lee KS.

Ann Oncol. 2010 Mar;21(3):488-92. doi: 10.1093/annonc/mdp510. Epub 2009 Nov 3.

PMID:
19887463
[PubMed - indexed for MEDLINE]
Free Article
12.

Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.

Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ.

Am J Clin Pathol. 2003 Nov;120(5):725-31.

PMID:
14608899
[PubMed - indexed for MEDLINE]
Free Article
13.

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.

Kashiwagi S, Yashiro M, Takashima T, Aomatsu N, Ikeda K, Ogawa Y, Ishikawa T, Hirakawa K.

Breast Cancer Res. 2011;13(6):R122. doi: 10.1186/bcr3068. Epub 2011 Nov 30.

PMID:
22126395
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.

Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW, Lee KS.

Ann Oncol. 2011 Aug;22(8):1755-62. doi: 10.1093/annonc/mdq678. Epub 2011 Feb 10.

PMID:
21310761
[PubMed - indexed for MEDLINE]
Free Article
15.

Heterogeneity of triple-negative breast cancer: mammographic, US, and MR imaging features according to androgen receptor expression.

Bae MS, Park SY, Song SE, Kim WH, Lee SH, Han W, Park IA, Noh DY, Moon WK.

Eur Radiol. 2014 Sep 16. [Epub ahead of print]

PMID:
25224727
[PubMed - as supplied by publisher]
16.

Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.

Wu K, Huang S, Zhu M, Lu Y, Chen J, Wang Y, Lin Q, Shen W, Zhang S, Zhu J, Shi YE, Weng Z.

Med Oncol. 2013;30(3):612. doi: 10.1007/s12032-013-0612-x. Epub 2013 May 22.

PMID:
23696021
[PubMed - indexed for MEDLINE]
17.

Androgen receptor in triple negative breast cancer.

McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H.

J Steroid Biochem Mol Biol. 2013 Jan;133:66-76. doi: 10.1016/j.jsbmb.2012.08.007. Epub 2012 Sep 5. Review.

PMID:
22982153
[PubMed - indexed for MEDLINE]
18.

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.

Loibl S, Müller BM, von Minckwitz G, Schwabe M, Roller M, Darb-Esfahani S, Ataseven B, du Bois A, Fissler-Eckhoff A, Gerber B, Kulmer U, Alles JU, Mehta K, Denkert C.

Breast Cancer Res Treat. 2011 Nov;130(2):477-87. doi: 10.1007/s10549-011-1715-8. Epub 2011 Aug 12.

PMID:
21837479
[PubMed - indexed for MEDLINE]
19.

[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009].

Svoboda M, Navrátil J, Fabian P, Palácová M, Gombošová J, Slámová L, Princ D, Syptáková B, Kudláček A, Bílek O, Pospíšil P, Kazda T, Grell P, Poprach A, Selingerová I, Nenutil R, Juráček J, Héžová R, Slabý O, Vyzula R.

Klin Onkol. 2012;25(3):188-98. Czech. Erratum in: Klin Onkol. 2013;26(2):139.

PMID:
22724568
[PubMed - indexed for MEDLINE]
20.

Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?

Arslan C, Isik M, Guler G, Kulac I, Solak M, Turker B, Ozisik Y, Altundag K.

Am Surg. 2012 Sep;78(9):992-9.

PMID:
22964210
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk